InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,131.60
(
-0.23%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.29
(
-0.22%
)
Bitcoin
61,116.97
(
0.50%
)
Post# of 13742
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

JediMozart

Send PM Follow Ignore
Followers 8
Posts 628
Boards Moderated 0
Alias Born 05/26/2021

JediMozart

Member Level

Re: None

Wednesday, 09/22/2021 11:43:49 AM

Wednesday, September 22, 2021 11:43:49 AM

Post# of 13742
“Escozine® has been shown to be effective in all of the pre-clinical proof-of-concept trials we have completed and successful completion of this study will propel the program forward into Phase II clinical trials.”

https://www.google.com/amp/s/finance.yahoo.com/amphtml/news/medolife-rx-launches-pharmacokinetic-study-110000337.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up